Fig. 3From: A type I combi-targeting approach for the design of molecules with enhanced potency against BRCA1/2 mutant- and O6-methylguanine-DNA methyltransferase (mgmt)- expressing tumour cellsSynthesis of ZSM02 from the acetylation of EG22 and its hydrolysis under physiological conditionsBack to article page